SGLT2 Inhibitors Linked to Reduced Rate of Stroke in Patients with Diabetes and AF
A study was conducted to determine the effect of SGLT2 inhibitors on embolic events in patients with atrial fibrillation and diabetes.
A study was conducted to determine the effect of SGLT2 inhibitors on embolic events in patients with atrial fibrillation and diabetes.
Erica Johnson, MD, discusses strategies to combat health misinformation in the wake of updates released by the CDC on recommendations for COVID-19 vaccination.